Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
AIDS Care|January 3, 2020
Risk factors for potentially preventable hospital readmissions among persons living with human immunodeficiency virus infectionGregory C Hadlock, Kelli Ann Moleres, Larry J Pineda, et al.British Journal of Haematology|March 1, 1975
Continuous flow centrifuge leucapheresis in the management of chronic myelogenous leukaemiaD C Hadlock, I E Fortuny, J McCullough, et al.Medical and Pediatric Oncology|January 1, 1976
Neutrophil leukocyte reserves in lymphoreticular malignanciesI E Fortuny, A Theologides, C Hadlock, et al.British Journal of Haematology|April 1, 1976
The role of continuous flow centrifuge leucapheresis in the management of chronic lymphocytic leukaemiaI E Fortuny, D C Hadlock, B J Kennedy, et al.Journal of Neuroscience Methods|February 5, 2011
Ex vivo identification of protein-protein interactions involving the dopamine transporterGregory C Hadlock, Chad C Nelson, Anthony J Baucum, et al.The Journal of Pharmacology and Experimental Therapeutics|July 13, 2010
Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activationGregory C Hadlock, Pei-Wen Chu, Elliot T Walters, et al.Transfusion|November 1, 1975
Granylocyte transfusion: a controlled study in patients with acuute nonlymphocytic leukemiaI E Fortuny, C D Bloomfield, D C Hadlock, et al.Journal of Neurochemistry|July 24, 2010
Methamphetamine alters vesicular monoamine transporter-2 function and potassium-stimulated dopamine releasePei-Wen Chu, Gregory C Hadlock, Paula Vieira-Brock, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|July 2, 2013
In vivo human time-exposure study of orally dosed commercial silver nanoparticlesMark A Munger, Przemyslaw Radwanski, Greg C Hadlock, et al.Neuropharmacology|August 7, 2013
Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotineS Charntikov, N Swalve, S Pittenger, et al.Pageof 2